Page last updated: 2024-10-30

maprotiline and Parkinson Disease

maprotiline has been researched along with Parkinson Disease in 5 studies

Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lauterbach, EC1
Victoroff, J1
Coburn, KL1
Shillcutt, SD1
Doonan, SM1
Mendez, MF1
Lefebvre, H1
Noblet, C1
Moore, N1
Wolf, LM1
Baykoushev, S2
Hadjipetrova, E1
Temenlieva, V2
Sandyk, R1

Reviews

1 review available for maprotiline and Parkinson Disease

ArticleYear
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
    The Journal of neuropsychiatry and clinical neurosciences, 2010,Winter, Volume: 22, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzo

2010

Other Studies

4 other studies available for maprotiline and Parkinson Disease

ArticleYear
Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.
    Clinical endocrinology, 1995, Volume: 42, Issue:1

    Topics: Bronchial Spasm; Bronchitis; Depressive Disorder; Diagnosis, Differential; Drug Interactions; Ephedr

1995
Ludiomil in the treatment of parkinsonism.
    Folia medica, 1989, Volume: 31, Issue:2

    Topics: Aged; Electromyography; Female; Humans; Male; Maprotiline; Middle Aged; Parkinson Disease

1989
Ludiomil in parkinsonism (EMG and clinical study).
    Folia medica, 1987, Volume: 29, Issue:4

    Topics: Anthracenes; Antidepressive Agents; Electromyography; Female; Humans; Male; Maprotiline; Parkinson D

1987
Maprotiline for disordered cognitive function in Parkinson's disease.
    Clinical pharmacy, 1986, Volume: 5, Issue:1

    Topics: Anthracenes; Cognition Disorders; Humans; Male; Maprotiline; Middle Aged; Parkinson Disease

1986